“All Prior Art is a project attempting to algorithmically create and publicly publish all possible new prior art, thereby making the published concepts not patent-able. The concept is to democratize ideas, provide an impetus for change in the patent system, and to preempt patent trolls. The system works by pulling text from the entire database of US issued and published (un-approved) patents and creating prior art from the patent language. While most inventions generated will be nonsensical, the cost to computationally create and publish millions of ideas is nearly zero – which allows for a higher probability of possible valid prior art.
Further, a large institution could dedicate many servers to this task, along with developing more advanced techniques such as deep learning, to flood the prior art space. It is not unforeseeable with current technology (along with sufficient cash for fees) to flood the actual patent application process itself with sufficiently advanced patent applications based on this concept.”
“As an academic non-profit research institute [associated with Harvard and MIT], Broad recognizes the unique role that such institutions play in propelling the biomedical ecosystem by exploring fundamental questions and working on risky, early-stage projects that often lack clear economic return.
To maximize its impact, our work (including discoveries, data, tools, technologies, knowledge, and intellectual property) should be made readily available for use, at no cost, by other academic and non-profit research institutions….
With respect to commercial licensing, our most important consideration is maximizing public benefit.
In most cases, we believe that this goal is best accomplished through non-exclusive licensing, which allows many companies to use innovations and thus compete to bring to market products incorporating them.
In some cases, we recognize that an exclusive license to an innovation may be necessary to justify the level of private investment required to develop a product and bring it to market. (An example is the composition-of-matter of drug. Without an exclusive license, a company would be reluctant to invest hundreds of millions of dollars in a clinical trial to demonstrate safety and efficacy, because competitors could subsequently ‘free-ride’ on their results to bring the same product to market.)
In each case, we evaluate the justification for exclusivity and seek to limit the scope of exclusivity….”
“Ultimately the question we are trying to resolve is how do we build organizations that communities trust and rely on to deliver critical infrastructures. Too often in the past we have used technical approaches, such as federation, to combat the fear that a system can be co-opted or controlled by unaccountable parties. Instead we need to consider how the community can create accountable and trustworthy organisations. Trust is built on three pillars: good governance (and therefore good intentions), capacity and resources (sustainability), and believable insurance mechanisms for when something goes wrong. These principles are an attempt to set out how these three pillars can be consistently addressed….”
“The Montreal Neurological Institute and Hospital becomes the first Open Science Institute in the world.
Open Science is a no-barrier approach to scientific research that is gaining ground within the academic community. Its principles are simple: allow research data and materials to move freely from one research team to another, between disciplines and toward the creation of innovative businesses….
MNI researchers will render all positive and negative numerical data, models used, data sources, reagents, algorithms, software and other scientific resources publicly available no later than the publication date of the first article that relies on this data or resource….
Subject to patient confidentiality and informed consent given, neither the MNI nor its researchers in their capacity as employees or consultants of the McGill- MNI unit will obtain patent protection or assert data protection rights in respect of any of their research….”
“Along with a number of leading Danish industrial companies, Aarhus University has opted out of the rat race in a new collaboration on industrially relevant basic research. Researchers and companies from all over Denmark publish all their results and data on the innovative Open Science platform, where the information is available free of charge to everyone interested….
The Open Science platform is thus the source of a number of paradigm shifts. It not only breaks away from the focus of universities on patenting their research discoveries, but also constitutes a conscious rebellion against the business models used by scientific journals….”
“The value and usefulness of patents should, in fact, not only demand an increase in their popularity but make them a first-choice source for those seeking chemical information….
A final, unavoidable truth is that research papers aren’t always free. When you try to access a highly relevant paper from a website, you may be greeted by a paywall.
The emergence of open access journals does present the synthetic chemist with a free method of acquiring chemical information. However, in general, medicinal chemists will not deviate from the staple intellectual diet of JACS, JOC, BMCL, Tet. Letts., Tetrahedron, Synthesis and Synlett. These are widely considered to be the best sources of the medicinal and synthetic organic chemistry but these titles are not very supportive of open access. Any serious chemical research entity will have to foot a large annual subscription bill to gain access to them.
In stark contrast, patents are freely available from the World Intellectual Property Organisation (WIPO)….The most important thing that a research chemist needs to know is that all patents are freely accessible to the public. All 55 million of them. Clearly, this is a data repository that rivals any journal title, especially when the cost to access this wealth of chemical information is zero….”
“Founded in 2010 by Virginie Simon, a biotech engineer and PhD in nanotechnology, and Tristan Davaille, a financial engineer with a degree in economics — MyScienceWork serves the international scientific community and the promotes easy access to scientific publications, unrestricted diffusion of knowledge and open science. Our comprehensive database includes more than 70 million scientific publications and 12 million patents.
We host a community of professional scientists and science enthusiasts from around the world who use MyScienceWork’s open network to deposit and discover scientific publications of all disciplines. Join the community!
For Research Institutions, Scientific Publishers & private-sector R&D companies, MyScienceWork provides a suite of data-driven solutions. Learn more about our products.
Our vision for the near future is to empower research institutions and industries with more intelligence related to research fields by aggregating all available data related to research results to accelerate findings, optimize funding and research efforts, improve transparency, bridge the knowledge gap between academia and industry and avoid duplicate research.
MySciencework believes that making science more accessible will foster data sharing amongst science organizations….”
“Why should universities continue to own and profit from publicly-funded work? If the public pays for it, why shouldn’t the public own it? … However, unlike governmental funding, the funds given by a private company to an academic researcher also come with an expectation of ownership. The trouble arises when the university is unwilling to fund the work but is also unwilling to cede ownership of the resulting invention. (As an aside, this is not unlike the longstanding debate on open access to scientific papers)….I can understand the institution retaining some claim on the IP alongside the public because they are providing the infrastructure to enable this work, which is effectively considered an extension of this work by their faculty. But when the university pulls back research funding entirely and expects financial support of “its own” scientists to come entirely from public grants or private contracts, and then “double dips” – detracting from these grants’ operating expenses to support the indirect costs of maintaining the research lab, then ownership of the resulting IP should pass to the funding parties….”
“Open source software has been one of the greatest sources of innovation. Open source developers have built excellent software solutions for business, education and personal use. Free and open source programs give companies, schools, governments and users more choices, ensuring that they are getting the best possible technology for their needs. Unfortunately, the last decade has seen an enormous rise in software patent suits. Open source developers aren’t any more immune to this threat than other software vendors. However, the culture and innovation modality of open source software, based on engagement and sharing, made it natural to build a collective defensive solution to protect and enable it.
The Open Invention Network is a shared defensive patent pool with the mission to protect Linux….”